Menu
Search
|

Menu

Close
X

Aethlon Medical Inc AEMD.OQ (NASDAQ Stock Exchange Capital Market)

1.28 USD
-0.01 (-0.78%)
As of 4:00 PM EDT
chart
Previous Close 1.29
Open 1.29
Volume 3,281
3m Avg Volume 24,405
Today’s High 1.29
Today’s Low 1.28
52 Week High 3.85
52 Week Low 0.80
Shares Outstanding (mil) 17.76
Market Capitalization (mil) 23.27
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 1 analysts

KEY STATS

Revenue (mm, USD)
FY18
0
FY17
0
FY16
1
FY15
1
EPS (USD)
FY18
-0.515
FY17
-0.936
FY16
-0.660
FY15
-1.359
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.86
Price to Sales (TTM)
vs sector
155.51
8.16
Price to Book (MRQ)
vs sector
3.73
4.20
Price to Cash Flow (TTM)
vs sector
--
22.15
Total Debt to Equity (MRQ)
vs sector
13.71
17.38
LT Debt to Equity (MRQ)
vs sector
13.71
13.24
Return on Investment (TTM)
vs sector
-139.52
13.13
Return on Equity (TTM)
vs sector
-166.79
15.07

EXECUTIVE LEADERSHIP

Charles Fisher
Independent Non-Executive Chairman of the Board, Since 2017
Salary: --
Bonus: --
Rodney Kenley
President, Director, Since 2010
Salary: $275,000.00
Bonus: --
James Joyce
Chief Executive Officer, Director, Since 2017
Salary: $385,000.00
Bonus: --
James Frakes
Chief Financial Officer, Senior Vice President - Finance, Since 2010
Salary: $235,000.00
Bonus: --
Edward Broenniman
Independent Director, Since 1999
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

9635 Granite Ridge Dr Ste 100
SAN DIEGO   CA   92123-2678

Phone: +1858.4597800

Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer.

SPONSORED STORIES